Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Abs

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 1, 1992
Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locusA Beckers, R Abs, P J Willems, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1992
Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 casesA Beckers, P Petrossians, R Abs, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
Cabergoline in the treatment of acromegaly: a study in 64 patientsR Abs, J Verhelst, D Maiter, et al.
European Journal of Endocrinology|August 18, 2009
From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysisM Klose, B Jonsson, R Abs, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|January 1, 1995
[Surgery and curietherapy of keloids]D Peiffert, J F Chassagne, M Pernot, et al.
Clinical Endocrinology|September 1, 1999
GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safetyR Abs, B A Bengtsson, E Hernberg-Stâhl, et al.
Neurochemistry International|March 1, 1997
125I-Tyr0-hCRH labelling characteristics of corticotropin-releasing hormone receptors: differences between normal and adenomatous corticotrophsR Abs, G Smets, G Vauquelin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiencyE Hernberg-Ståhl, A Luger, R Abs, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1994
Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type I syndromeA Beckers, R Abs, E Reyniers, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International BoardB A Bengtsson, R Abs, H Bennmarker, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|August 1, 1992
Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locusA Beckers, R Abs, P J Willems, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1992
Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 casesA Beckers, P Petrossians, R Abs, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
Cabergoline in the treatment of acromegaly: a study in 64 patientsR Abs, J Verhelst, D Maiter, et al.
European Journal of Endocrinology|August 18, 2009
From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysisM Klose, B Jonsson, R Abs, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|January 1, 1995
[Surgery and curietherapy of keloids]D Peiffert, J F Chassagne, M Pernot, et al.
Clinical Endocrinology|September 1, 1999
GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safetyR Abs, B A Bengtsson, E Hernberg-Stâhl, et al.
Neurochemistry International|March 1, 1997
125I-Tyr0-hCRH labelling characteristics of corticotropin-releasing hormone receptors: differences between normal and adenomatous corticotrophsR Abs, G Smets, G Vauquelin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiencyE Hernberg-Ståhl, A Luger, R Abs, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1994
Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type I syndromeA Beckers, R Abs, E Reyniers, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International BoardB A Bengtsson, R Abs, H Bennmarker, et al.
Pageof 8